Cargando…
ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients
BACKGROUND: Receptor tyrosine-protein kinase erbB-2 (ERBB2) expression is a critical factor for the prognosis of various cancers. ERBB2 enrichment indicates a poor prognosis in some cancer types but could be a favorable prognostic factor in others. METHODS: We analyzed DNA methylation, mRNA, protein...
Autores principales: | Wang, Hongting, Jiang, Yongxu, Jin, Huanhuan, Wang, Cunqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511046/ https://www.ncbi.nlm.nih.gov/pubmed/36172165 http://dx.doi.org/10.3389/fonc.2022.1012138 |
Ejemplares similares
-
RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022) -
Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022) -
PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022) -
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
por: Tang, Shasha, et al.
Publicado: (2023) -
USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance
por: Jin, RuiRi, et al.
Publicado: (2023)